Assembly Biosciences, Inc.

NASDAQ:ASMB

Biotechnology

Healthcare
$22.39 +0.66%

+$0.16 today

Market cap
$458.48M
Beta
1.08
P/E (TTM)
-64.4
EPS (TTM)
-$0.38
52W Low $16.50High $39.71

Volume 0.49M

Average 0.17M

Balance Sheet

Inspect the capital base behind the business.

Assets

$257.59M

FY 2025 · Annual

+116.2% YoY

Liabilities

$50.84M

FY 2025 · Annual

-40.8% YoY

Equity

$206.75M

FY 2025 · Annual

+519.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents45.63M52.42M19.84M38.34M58.45M
Short-term Investments101M39.19M110.41M73.74M189.66M
Net Receivables336K944K43K400K974K
Inventory00(3.2M)00
Other Current Assets0300K3.5M3.02M5.47M
Total Current Assets154.2M96.97M133.79M115.5M254.55M
Property, Plant & Equipment (Net)7.18M3.94M2.72M3.35M2.73M
Goodwill00000
Intangible Assets00000
Long-term Investments27.97M0000
Tax Assets00000
Other Non-current Assets1.7M889K312K312K312K
Total Non-current Assets36.86M4.83M3.04M3.67M3.04M
Total Assets191.06M101.79M136.82M119.17M257.59M
Account Payables2.66M2.49M461K585K1.17M
Short-term Debt00000
Tax Payables00000
Deferred Revenue0030.92M37.62M36.9M
Other Current Liabilities6.43M599K1.15M6.48M7.52M
Total Current Liabilities16.07M16.3M39.23M47.8M48.78M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)2.73M055.38M00
Other Non-current Liabilities02.73M035.38M0
Total Non-current Liabilities6.06M2.83M56.5M38.01M2.06M
Total Liabilities22.13M19.13M95.73M85.81M50.84M
Common Stock48K4K5K7K16K
Retained Earnings(631.43M)(724.52M)(785.75M)(825.93M)(832.05M)
Accumulated OCI(419K)(803K)(81K)(211K)(41K)
Other Stockholders Equity0(1)000
Minority Interest00000
Total Equity168.93M82.66M41.1M33.36M206.75M
Total Debt6.48M3.47M2.34M3.09M2.63M
Net Debt(39.15M)(48.95M)(17.5M)(35.26M)(55.82M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$31.1M
Short-term Investments$195.5M
Receivables$451.0K
Other Current$5.6M
Total Current Assets$232.6M
PP&E (Net)$2.6M
Other Non-current$312.0K
Total Non-current Assets$2.9M
Total Assets$235.5M

Analysis

Selected assets total $235.5M for Latest. The largest visible component is Short-term Investments at $195.5M, about 83.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026

How much cash does ASMB have?

Assembly Biosciences, Inc. (ASMB) reported $58.45M in cash and equivalents in fiscal 2025.

How much debt does ASMB carry?

Assembly Biosciences, Inc. (ASMB) reported $2.63M of total debt, with net debt of -$55.82M.